COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Monk, BJ; Coleman, RL; Moore, KN; Herzog, TJ; Secord, AA; Matulonis, UA; Slomovitz, BM; Guntupalli, SR; O'Malley, DM

Published Date

  • July 2020

Published In

Volume / Issue

  • 158 / 1

Start / End Page

  • 34 - 36

PubMed ID

  • 32370991

Pubmed Central ID

  • 32370991

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2020.04.703

Language

  • eng

Conference Location

  • United States